Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 88,499 | 71,323 | 49,087 | 38,212 | 54,506 |
| Cost of Goods | 16,719 | 15,573 | 13,010 | 14,154 | 30,518 |
| Gross Profit | 71,780 | 55,750 | 36,077 | 24,058 | 23,988 |
| Operating Expenses | 100,372 | 90,821 | 77,429 | 74,799 | 65,446 |
| Operating Income | -27,873 | -34,498 | -41,342 | -50,587 | -40,940 |
| Interest Expense | 7,716 | 8,258 | 9,536 | 8,072 | 4,508 |
| Other Income | 324 | -175 | -1,268 | -6,788 | 2,289 |
| Pre-tax Income | -35,265 | -42,931 | -52,146 | -65,447 | -43,159 |
| Net Income Continuous | -35,265 | -42,931 | -52,146 | -65,447 | -43,159 |
| Net Income | $-35,265 | $-42,931 | $-52,146 | $-65,447 | $-43,159 |
| EPS Basic Total Ops | -4.67 | -6.64 | -12.80 | -31.00 | -31.60 |
| EPS Basic Continuous Ops | -4.67 | -6.64 | -12.70 | -31.09 | -31.54 |
| EPS Diluted Total Ops | -4.67 | -6.64 | -12.80 | -31.00 | -31.60 |
| EPS Diluted Continuous Ops | -4.67 | -6.64 | -12.70 | -31.09 | -31.54 |
| EPS Diluted Before Non-Recurring Items | -4.67 | -6.60 | -12.40 | -27.60 | -32.80 |
| EBITDA(a) | $-20,861 | $-26,342 | $-30,680 | $-39,625 | $-35,056 |